קם-רהו די

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

ANTI-D IMMUNOGLOBULINS

제공처:

KAMADA LTD, ISRAEL

ATC 코드:

J06BB01

약제 형태:

תמיסה להזרקה

구성:

ANTI-D IMMUNOGLOBULINS 150 MCG / 1 ML

관리 경로:

תוך-ורידי

처방전 유형:

מרשם נדרש

Manufactured by:

KAMADA LTD, ISRAEL

치료 그룹:

ANTI-D (RH) IMMUNOGLOBULIN

치료 영역:

ANTI-D (RH) IMMUNOGLOBULIN

치료 징후:

Suppression of Rh immunization in non-sensitized Rho(D) negative women delivering an Rh positive baby, or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions, threatened abortion associated with maternal bleeding amniocentesis, chorionic villus sampling ruptured tubal pregnancy, and significant abdominal trauma. KAM-Rho should be given within 72 hours of event. Immune thrombocytopenic purpura (ITP): Rho (d)-positive adults with chronic ITP, children with chronic or acute ITP, and patients with Thrombocytopenia secondary to HIV infection in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage.

승인 날짜:

2013-03-31